Markets › News › DeFi

Injective Proposes Canary Staked INJ ETF for Token Exposure with Staking Rewards

A new ETF aims to provide INJ token exposure alongside staking rewards through traditional brokerage accounts.

A new ETF aims to provide INJ token exposure alongside staking rewards through traditional brokerage accounts. Injective (INJ) is trading at $8.03, down 0.1% since this brief published. This is an original TLT brief based on reporting by TronWeekly, with live market data added, as of Thu, 22 Oct 2026 19:00:06 UTC.

Why it matters

This ETF could democratize access to Injective's staking rewards through traditional financial channels, though it introduces complexities of market volatility and reward uncertainty.

Key takeaways
  • Canary Staked INJ ETF aims to combine INJ token exposure with staking rewards.
  • Investors could access staking via brokerage accounts, not just crypto platforms.
  • Returns are not guaranteed and the fund faces INJ price volatility risks.
The story so far · 2 briefs
  1. Injective Token Surges 25% Weekly Amid US Regulatory Talks and Institutional Interest
  2. Injective Proposes Canary Staked INJ ETF for Token Exposure with Staking Rewards — this brief

The Canary Staked INJ ETF is designed to offer investors a novel way to gain exposure to Injective's INJ token while also benefiting from staking rewards.

This ETF structure aims to bridge the gap between traditional finance and decentralized finance by allowing investors to access staking rewards through brokerage accounts.

While the concept introduces an innovative way to combine token investment with staking, it is important to note that the rewards are not assured and the fund would still be subject to the price volatility of the underlying INJ token.

The development comes as Injective's native token, INJ, is currently trading at $8.04, having fallen 7.04% in the past 24 hours and 1.03% over the past week. The broader crypto market is also experiencing a downturn, with the total market cap at $2.78 trillion.

This ETF proposal could potentially attract more mainstream investors to Injective's ecosystem by offering a familiar financial product with the added benefit of staking rewards. However, the success of the ETF will depend on how well it can balance the risks and rewards for investors.

Market reaction since this brief Live

Since this brief published about 1 hour ago, Injective (INJ) has moved from $8.04 to $8.03 — -0.12%.

$8.03$8.03$8.04$8.04$8.04 published · $8.04 now · $8.03 (-0.12%) Oct 22 18:00 UTC Oct 22 19:00 UTC
BeforeSince publishPublished · $8.04

The chart plots INJ's price: grey is the move before this brief published, the vertical dashed line marks the moment it published, the horizontal dashed line is the price then, and the coloured area is the move since — from TLT's market data (daily resolution). It shows what happened after the news, not that the news caused it; many factors move prices. Not financial advice.

What this means in naira

At today's peer-to-peer rate, 1 INJ ≈ ₦10,981.43 (about $8.03), down 6.1% over 24 hours. The naira itself trades about 2.5% above the official rate on the P2P market, so a Nigerian buyer's effective cost differs from the headline dollar price.

Live market data

Current prices for the asset in this story — live, source-stamped, updated every 15 minutes.

#86
$8.03 ▼ 6.09%
-0.12% since this brief published
7d -1.03%MCap $803.34MFull INJ data →
The market when this published · October 22, 2026
Total market cap$2.78T
Bitcoin 24h-4.25%
Ethereum 24h-5.52%
BTC dominance58.5%
Fear & Greed68 · Greed
On-chain & primary-source check

Figures and sectors in this story, checked live against on-chain aggregators · October 22, 2026.

SectorCross-chain bridges$10.23Bacross 30 protocolsDeFiLlama ↗

TLT reads these figures directly from on-chain aggregators (DeFiLlama, mempool.space) at build time — independent of what any outlet reported. Sector totals aggregate every protocol DeFiLlama tracks in that category. Values are live and will change.

Injective Proposes Canary Staked INJ ETF for Token Exposure — questions & answers

What is the Canary Staked INJ ETF?

It is an ETF designed to provide exposure to Injective's INJ token while incorporating staking rewards into the fund's structure.

How does the ETF provide access to staking rewards?

The ETF aims to allow investors to access staking rewards through traditional brokerage accounts, not just crypto platforms.

What are the risks associated with the ETF?

The ETF faces risks from the price volatility of the INJ token and the uncertainty of staking rewards.

How much is 1 Injective worth in naira today?

About ₦10,981.43 at the live peer-to-peer (P2P) USDT rate, which is what Nigerians typically trade at — equivalent to roughly $8.03. The naira price moves with both INJ's US-dollar price and the USDT/NGN rate; use our Injective in naira page for any amount.

Has Injective's price moved since this brief was published?

INJ is down 0.12% since this brief first published — trading at $8.03 now versus $8.04 at publication. TLT re-checks this figure against CoinGecko and Binance every 15 minutes.

Which outlets reported this story?

This is an original TLT brief that synthesises reporting from TronWeekly. It is not a copy of any one article — follow the source links above for the original reporting.

TLT Newsdesk Data-stamped

TLT's newsdesk writes original briefs by synthesising coverage from across the crypto press — 50+ outlets including CoinDesk, The Block, Decrypt and Cointelegraph — cross-checking the figures they report — and verifying them against on-chain data from DeFiLlama and mempool.space — plus live market context (CoinGecko, Binance). We summarise and link to every source; we never reproduce full articles. Read our editorial standards and how we use AI. Not financial advice.

Market data verified against CoinGecko & Binance · October 22, 2026 ⛓ Timestamped at Bitcoin block #972,640 sha256:591e32e906f3bb04
Based on reporting by TronWeekly — this is an original TLT summary with live market data, not the original article.TronWeekly · Oct 22 18:00 ↗

Original summary — not financial advice. This is an original TLT brief that summarises a development reported elsewhere and adds live market data for context; it is not the original article and reproduces no part of it. Follow the source link above for full details. Crypto is volatile and high-risk — always do your own research.